N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide

C129H130FN21O7 — CID 162252282

IUPACN-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide
SMILESCOc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCCCC4)ccc32)c1.COc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCNCC4)ccc32)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCCCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCNCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(F)ccc3n2-c2ccccc2)c1
InChIInChI=1S/C28H30N4O2.C27H29N5O2.C27H28N4O.C26H27N5O.C21H16FN3O/c1-20-8-6-9-22(16-20)27(33)30-28-29-25-17-21(19-31-14-4-3-5-15-31)12-13-26(25)32(28)23-10-7-11-24(18-23)34-2;1-19-5-3-6-21(15-19)26(33)30-27-29-24-16-20(18-31-13-11-28-12-14-31)9-10-25(24)32(27)22-7-4-8-23(17-22)34-2;1-20-9-8-10-22(17-20)26(32)29-27-28-24-18-21(19-30-15-6-3-7-16-30)13-14-25(24)31(27)23-11-4-2-5-12-23;1-19-6-5-7-21(16-19)25(32)29-26-28-23-17-20(18-30-14-12-27-13-15-30)10-11-24(23)31(26)22-8-3-2-4-9-22;1-14-6-5-7-15(12-14)20(26)24-21-23-18-13-16(22)10-11-19(18)25(21)17-8-3-2-4-9-17/h6-13,16-18H,3-5,14-15,19H2,1-2H3,(H,29,30,33);3-10,15-17,28H,11-14,18H2,1-2H3,(H,29,30,33);2,4-5,8-14,17-18H,3,6-7,15-16,19H2,1H3,(H,28,29,32);2-11,16-17,27H,12-15,18H2,1H3,(H,28,29,32);2-13H,1H3,(H,23,24,26)
InChIKeyZYDGZTKNVUMEIF-UHFFFAOYSA-N
MW2105.60 g/mol
LogP23.87
Rot. Bonds25

About N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide

N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide (PubChem CID 162252282) has the molecular formula C129H130FN21O7 and a molecular weight of 2105.60 g/mol. Its IUPAC name is N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide.

Molecular Properties

Compound NameN-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide
PubChem CID162252282
Molecular FormulaC129H130FN21O7
Molecular Weight2105.60 g/mol
Exact Mass2104.04
IUPAC NameN-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide
SMILESCOc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCCCC4)ccc32)c1.COc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCNCC4)ccc32)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCCCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCNCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(F)ccc3n2-c2ccccc2)c1
InChIInChI=1S/C28H30N4O2.C27H29N5O2.C27H28N4O.C26H27N5O.C21H16FN3O/c1-20-8-6-9-22(16-20)27(33)30-28-29-25-17-21(19-31-14-4-3-5-15-31)12-13-26(25)32(28)23-10-7-11-24(18-23)34-2;1-19-5-3-6-21(15-19)26(33)30-27-29-24-16-20(18-31-13-11-28-12-14-31)9-10-25(24)32(27)22-7-4-8-23(17-22)34-2;1-20-9-8-10-22(17-20)26(32)29-27-28-24-18-21(19-30-15-6-3-7-16-30)13-14-25(24)31(27)23-11-4-2-5-12-23;1-19-6-5-7-21(16-19)25(32)29-26-28-23-17-20(18-30-14-12-27-13-15-30)10-11-24(23)31(26)22-8-3-2-4-9-22;1-14-6-5-7-15(12-14)20(26)24-21-23-18-13-16(22)10-11-19(18)25(21)17-8-3-2-4-9-17/h6-13,16-18H,3-5,14-15,19H2,1-2H3,(H,29,30,33);3-10,15-17,28H,11-14,18H2,1-2H3,(H,29,30,33);2,4-5,8-14,17-18H,3,6-7,15-16,19H2,1H3,(H,28,29,32);2-11,16-17,27H,12-15,18H2,1H3,(H,28,29,32);2-13H,1H3,(H,23,24,26)
InChIKeyZYDGZTKNVUMEIF-UHFFFAOYSA-N
XLogP23.87
TPSA290.08 Ų
H-Bond Donors7
H-Bond Acceptors23
Rotatable Bonds25
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002105.60
LogP ≤ 523.87
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1023

Analyze N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide?
The IUPAC name of N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide (CID 162252282) is N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide.
What is the SMILES notation for N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide?
The canonical SMILES for N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide is COc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCCCC4)ccc32)c1.COc1cccc(-n2c(NC(=O)c3cccc(C)c3)nc3cc(CN4CCNCC4)ccc32)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCCCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(CN4CCNCC4)ccc3n2-c2ccccc2)c1.Cc1cccc(C(=O)Nc2nc3cc(F)ccc3n2-c2ccccc2)c1.
What is the InChIKey of N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide?
The InChIKey is ZYDGZTKNVUMEIF-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H30N4O2.C27H29N5O2.C27H28N4O.C26H27N5O.C21H16FN3O/c1-20-8-6-9-22(16-20)27(33)30-28-29-25-17-21(19-31-14-4-3-5-15-31)12-13-26(25)32(28)23-10-7-11-24(18-23)34-2;1-19-5-3-6-21(15-19)26(33)30-27-29-24-16-20(18-31-13-11-28-12-14-31)9-10-25(24)32(27)22-7-4-8-23(17-22)34-2;1-20-9-8-10-22(17-20)26(32)29-27-28-24-18-21(19-30-15-6-3-7-16-30)13-14-25(24)31(27)23-11-4-2-5-12-23;1-19-6-5-7-21(16-19)25(32)29-26-28-23-17-20(18-30-14-12-27-13-15-30)10-11-24(23)31(26)22-8-3-2-4-9-22;1-14-6-5-7-15(12-14)20(26)24-21-23-18-13-16(22)10-11-19(18)25(21)17-8-3-2-4-9-17/h6-13,16-18H,3-5,14-15,19H2,1-2H3,(H,29,30,33);3-10,15-17,28H,11-14,18H2,1-2H3,(H,29,30,33);2,4-5,8-14,17-18H,3,6-7,15-16,19H2,1H3,(H,28,29,32);2-11,16-17,27H,12-15,18H2,1H3,(H,28,29,32);2-13H,1H3,(H,23,24,26).
What are the key properties of N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide?
N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide has a molecular weight of 2105.60 g/mol, XLogP of 23.87, 25 rotatable bonds, 7 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-fluoro-1-phenylbenzimidazol-2-yl)-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;N-[1-(3-methoxyphenyl)-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]-3-methylbenzamide;3-methyl-N-[1-phenyl-5-(piperazin-1-ylmethyl)benzimidazol-2-yl]benzamide;3-methyl-N-[1-phenyl-5-(piperidin-1-ylmethyl)benzimidazol-2-yl]benzamide is sourced from PubChem (CID 162252282), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).